TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Ame Bioscience AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
5,802
|
20,052
|
24,468 |
Financial expenses |
23
|
96
|
35 |
Earnings before taxes |
1,086
|
4,119
|
5,852 |
Total assets |
5,294
|
8,101
|
19,489 |
Current assets |
5,289
|
8,094
|
19,480 |
Current liabilities |
1,239
|
1,093
|
15,692 |
Equity capital |
4,055
|
7,008
|
3,796 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) | 1 | 1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
76.6%
|
86.5%
|
19.5% |
Turnover per employee | 5,802 | 24,468 | |
Profit as a percentage of turnover |
18.7%
|
20.5%
|
23.9% |
Return on assets (ROA) |
20.9%
|
52.0%
|
30.2% |
Current ratio |
426.9%
|
740.5%
|
124.1% |
Return on equity (ROE) |
26.8%
|
58.8%
|
154.2% |
Change turnover |
-14,250
|
-4,416
|
22,878 |
Change turnover % |
-71%
|
-18%
|
1439% |
Chg. No. of employees | 0 | ||
Chg. No. of employees % | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.